Stay updated with breaking news from Nasdaq Fnch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 10,600 shares, an increase of 15.2% from the March 31st total of 9,200 shares. Based on an average daily trading volume, of […]
Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Free Report) saw a significant increase in short interest during the month of August. As of August 15th, there was short interest totalling 21,400 shares, an increase of 57.4% from the July 31st total of 13,600 shares. Currently, 3.8% of the shares of the company are short sold. […]
Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Free Report) traded down 1.5% on Tuesday . The company traded as low as $6.11 and last traded at $6.45. 8,666 shares were traded during trading, a decline of 53% from the average session volume of 18,409 shares. The stock had previously closed at $6.55. Finch Therapeutics Group […]
Shares of Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Free Report) fell 1.5% on Tuesday . The stock traded as low as $6.11 and last traded at $6.45. 8,666 shares traded hands during mid-day trading, a decline of 53% from the average session volume of 18,409 shares. The stock had previously closed at $6.55. Finch […]
Shares of Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Rating) are set to reverse split before the market opens on Monday, June 12th. The 1-30 reverse split was announced on Monday, June 12th. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, June 12th. Finch Therapeutics Group Stock […]